Summary
Colorado has recently become the first state to explicitly safeguard neural data privacy, enacting a law on Wednesday, April 17th, 2024. Essentially, this legislation acknowledges that data generated by the nervous system is sensitive.
Supporters in Colorado expressed concerns that without proper safeguards, new devices might enable malicious actors to manipulate an individual's thoughts. Lawmakers in California and Minnesota are similarly evaluating protections for neural data.
Modern healthcare and medical research heavily rely on technology and data. As new technologies emerge, they bring expanded challenges for privacy. The recent move by Colorado demonstrates that regulatory frameworks must remain adaptable and flexible, evolving to cover new scenarios that might not have been envisioned just a few years ago. This is particularly relevant for neurodata and neurotechnology.
FAQs
Our frequently questions
Find out how iliomad can help your company.
Only visible in production
Healthcare AI Agents, Vendor Breaches and GDPR Reforms: Weekly Privacy and Regulation Digest
This week's digest covers autonomous AI agent risks, a wave of US healthcare vendor breaches, the EU Digital Omnibus GDPR mandate and Swiss voice-biometric enforcement.
Clinical study protocol data protection: a practical guide for sponsors
Learn how to embed GDPR-compliant data protection into your clinical study protocol. Practical guidance on Section 13, DPIAs, transfers and local formalities.
Clinical Site Agreement: Navigating US Export Control Review of Cross-Border Data Transfers in Clinical Trials
Learn how institutional export control policies at clinical sites affect cross-border data transfers in trials, even below DOJ Bulk Data Rule thresholds.
